Suchen
Entera Bio Ltd
ENTXZur Watchlist hinzufügen
2.960USD
+0.100+3.50%
Handelsschluss 09-16 16:00（ET）
145.90MMarktkapitalisierung
VerlustKGV TTM
mehr Informationen über Entera Bio Ltd Unternehmen
Entera Bio Ltd is an Israel-based clinical-stage biopharmaceutical company focused on the development and commercialization of orally delivered large molecule therapeutics for use in areas with unmet medical need and where adoption of injectable therapies is limited due to cost, convenience and compliance challenges for patients. The Company developed a platform that enables the oral delivery of injectable proteins and large molecules. Entera Bio candidates are EB613 for the treatment of osteoporosis and EB612 for the treatment of hypoparathyroidism. Both EB613 and EB612 are oral formulations of human parathyroid hormone (1-34), or Parathormon (PTH). The products are administered via injection.
Entera Bio Ltd Profil
BörsenkürzelENTX
Name des UnternehmensEntera Bio Ltd
IPO-datumJun 28, 2018
CEOToledano (Miranda Jayne)
Anzahl der mitarbeiter18
WertpapierartOrdinary Share
GeschäftsjahresendeJun 28
AddresseHadassah / Jerusalem Bio
StadtJERUSALEM
BörseNASDAQ OMX - NASDAQ BASIC
LandIsrael
Postleitzahl9112002
Telefon97225327151
Websitehttps://enterabio.com/
BörsenkürzelENTX
IPO-datumJun 28, 2018
CEOToledano (Miranda Jayne)
Führungskräfte von Entera Bio Ltd
Name
Name/Position
Position
Aktienbesitz
Veränderung
Ms. Miranda Jayne Toledano
Ms. Miranda Jayne Toledano
Chief Executive Officer, Director
Chief Executive Officer, Director
847.13K
+49.64%
Ms. Miranda Jayne Toledano
Ms. Miranda Jayne Toledano
Chief Executive Officer, Director
Chief Executive Officer, Director
847.13K
+49.64%
Mr. Gerald M. (Jerry) Lieberman
Mr. Gerald M. (Jerry) Lieberman
Independent Chairman of the Board
Independent Chairman of the Board
363.25K
+10.54%
Mr. Sean Ellis
Mr. Sean Ellis
Independent Director
Independent Director
208.13K
+9.63%
Mr. Sean Ellis
Mr. Sean Ellis
Independent Director
Independent Director
208.13K
+9.63%
Ms. Haya Taitel
Ms. Haya Taitel
Independent Director
Independent Director
119.27K
+17.43%
Ms. Haya Taitel
Ms. Haya Taitel
Independent Director
Independent Director
119.27K
+17.43%
Mr. Yonatan Malca
Mr. Yonatan Malca
Independent Director
Independent Director
82.23K
+27.75%
Mr. Yonatan Malca
Mr. Yonatan Malca
Independent Director
Independent Director
82.23K
+27.75%
Mr. Gerald M. (Jerry) Ostrov
Mr. Gerald M. (Jerry) Ostrov
Independent Director
Independent Director
75.66K
+37.96%
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Ms. Miranda Jayne Toledano
Ms. Miranda Jayne Toledano
Chief Executive Officer, Director
Chief Executive Officer, Director
847.13K
+49.64%
Ms. Miranda Jayne Toledano
Ms. Miranda Jayne Toledano
Chief Executive Officer, Director
Chief Executive Officer, Director
847.13K
+49.64%
Mr. Gerald M. (Jerry) Lieberman
Mr. Gerald M. (Jerry) Lieberman
Independent Chairman of the Board
Independent Chairman of the Board
363.25K
+10.54%
Mr. Sean Ellis
Mr. Sean Ellis
Independent Director
Independent Director
208.13K
+9.63%
Mr. Sean Ellis
Mr. Sean Ellis
Independent Director
Independent Director
208.13K
+9.63%
Ms. Haya Taitel
Ms. Haya Taitel
Independent Director
Independent Director
119.27K
+17.43%
Häufig gestellte Fragen
Wer sind die fünf größten Anteilseigner von Entera Bio Ltd?
Die fünf größten Anteilseigner von Entera Bio Ltd sind: Ms. Miranda Jayne Toledano
Wie viele Institutionen halten Anteile an Entera Bio Ltd (ENTX)?
Mit Stand vom 2026Q1 halten 34 Institutionen Anteile an Entera Bio Ltd, mit einem Gesamtmarktwert von etwa 9.31M, was 17.10% der Gesamtanteile entspricht. Im Vergleich zum 2025Q4 ist der institutionelle Aktienbesitz um -4212.00 gestiegen.